CIK 0001907108
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Lexeo Therapeutics, Inc.
Sign in to watch- Ticker
- LXEO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 854012572
- Phone
- +1 212-547-9879
- Business address
- 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 26,875 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 43,750 shares (grant or award)
- 4 Grant or award Chief Legal and Admin Officer acquired 23,750 shares (grant or award)
- 4 Open-market buy 10% owner bought 454,545 shares at $11.00 ($4,999,995)
- 4 Conversion Chief Technical Officer acquired 3,191 shares (conversion)
- 4 Open-market buy 10% owner bought 227,272 shares at $11.00 ($2,499,992)
- 4 Open-market buy 10% owner bought 454,545 shares at $11.00 ($4,999,995)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 7 · 123 filings